amotosalen has been researched along with Bacterial Disease in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (66.67) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benjamin, RJ; Braschler, T; Corash, LM; Weingand, T | 1 |
Cazenave, JP; D'Alessandro, A; Devine, DV; Gachet, C; Greinacher, A; Lion, N; Prudent, M; Schubert, P; Steil, L; Thiele, T; Tissot, JD; Völker, U; Zolla, L | 1 |
Brand, A; de Greef, GE; Huijgens, PC; Kerkhoffs, JL; Luten, M; Novotny, VM; Schipperus, MR; Te Boekhorst, PA; van Pampus, LC; van Putten, WL; van Rhenen, DJ; Zwaginga, JJ | 1 |
Corash, L | 1 |
Buchholz, D; Cazenave, JP; Conlan, M; Corash, L; Davis, K; de Greef, G; Flament, J; Gulliksson, H; Kappers-Klunne, M; Klüter, H; Laforet, M; Lin, L; Lioure, B; Ljungman, P; Marblie, S; Mayaudon, V; Metzel, P; Pamphilon, D; van Rhenen, D; Vermeij, H | 1 |
Snyder, EL; Wu, YY | 1 |
Beckers, EA; Jansen, GA; Leebeek, FW; Sonneveld, P; van Rhenen, DJ; van Vliet, HH; Vermeij, H | 1 |
Gathof, BS; Picker, SM; Speer, R | 1 |
Beris, P; Cazenave, JP; Conlan, MG; Flament, J; Hastka, J; Janetzko, K; Kientz, D; Klüter, H; Lin, JS; Lin, L; Lioure, B; Marblie, S; Mayaudon, V; Michel, M | 1 |
Corash, L; Lawrie, AS; Machin, SJ; Mackie, IJ; Pinkoski, L; Yarranton, H | 1 |
Bruchmüller, I; Bugert, P; Corash, L; Janetzko, K; Klüter, H; Lin, L; Mayaudon, V | 1 |
Conlan, MG; Corash, L; Lin, JS; Lopez-Plaza, I; McCullough, J; Slichter, SJ; Snyder, E; Strauss, RG | 1 |
2 review(s) available for amotosalen and Bacterial Disease
Article | Year |
---|---|
Proteome changes in platelets after pathogen inactivation--an interlaboratory consensus.
Topics: Bacterial Infections; Blood Banks; Blood Platelets; Blood Preservation; Furocoumarins; Hemostasis; Humans; Parasitic Diseases; Photochemistry; Proteome; Proteomics; Reproducibility of Results; Riboflavin; Ultraviolet Rays; Virus Diseases | 2014 |
Safety of the blood supply: role of pathogen reduction.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aziridines; Bacterial Infections; Blood; Blood Banks; Blood Transfusion; Furocoumarins; Humans; Riboflavin; Virus Diseases | 2003 |
4 trial(s) available for amotosalen and Bacterial Disease
Article | Year |
---|---|
Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction.
Topics: Adult; Aged; Bacterial Infections; Blood Platelets; Blood Preservation; Female; Furocoumarins; Hemorrhage; Humans; Leukocyte Reduction Procedures; Male; Middle Aged; Plasma; Platelet Transfusion; Thrombocytopenia; Treatment Outcome; Ultraviolet Rays; Virus Diseases | 2010 |
Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial.
Topics: Adult; Bacterial Infections; Blood Group Incompatibility; Blood Preservation; Double-Blind Method; Erythrocyte Transfusion; Female; Furocoumarins; Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Photochemistry; Photosensitizing Agents; Platelet Count; Platelet Transfusion; Specimen Handling; Thrombocytopenia; Time Factors; Ultraviolet Rays; Virus Diseases | 2003 |
Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set.
Topics: Adult; Aged; Antibodies; Bacterial Infections; Blood Component Removal; Erythrocyte Transfusion; Female; Furocoumarins; Hemorrhage; Humans; Male; Middle Aged; Photochemistry; Platelet Count; Platelet Transfusion; Thrombocytopenia; Ultraviolet Rays | 2005 |
Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial.
Topics: Adult; Bacteria; Bacterial Infections; Blood Banking; Blood Banks; Cause of Death; Female; Furocoumarins; Hemorrhage; Humans; Incidence; Male; Middle Aged; Platelet Transfusion; Plateletpheresis; Safety; Skin Diseases; Thrombocytopenia; Thrombosis; Ultraviolet Rays | 2005 |
6 other study(ies) available for amotosalen and Bacterial Disease
Article | Year |
---|---|
Hemovigilance monitoring of platelet septic reactions with effective bacterial protection systems.
Topics: Bacterial Infections; Bacteriological Techniques; Blood Platelets; Blood Safety; Disinfection; Europe; Furocoumarins; Humans; Photosensitizing Agents; Transfusion Reaction; Ultraviolet Rays | 2017 |
Bacterial contamination of platelet components: potential solutions to prevent transfusion-related sepsis.
Topics: Bacteria; Bacterial Infections; Blood Platelets; Disinfection; Ficusin; Furocoumarins; Humans; Nucleic Acids; Platelet Transfusion; Riboflavin; Risk Factors; Sepsis; Ultraviolet Rays | 2011 |
Functional characteristics of photochemically treated platelets.
Topics: Apoptosis; Bacterial Infections; Blood Platelets; Blood Preservation; Furocoumarins; Humans; Photochemistry; Platelet Aggregation; Ultraviolet Rays | 2004 |
Functional characteristics of buffy-coat PLTs photochemically treated with amotosalen-HCl for pathogen inactivation.
Topics: Bacterial Infections; Blood Platelets; Blood Preservation; Carbon Dioxide; Cell Survival; Furocoumarins; Glucose; Humans; Hydrogen-Ion Concentration; L-Lactate Dehydrogenase; Osmotic Pressure; Oxygen; Photochemistry; Platelet Aggregation; Platelet Count | 2004 |
Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A light.
Topics: Bacterial Infections; Blood Coagulation Factors; Blood Proteins; Cryopreservation; Furocoumarins; Hemostasis; Humans; In Vitro Techniques; Photochemistry; Plasma; Purpura, Thrombotic Thrombocytopenic; Ultraviolet Rays | 2005 |
Polymerase chain reaction inhibition assay documenting the amotosalen-based photochemical pathogen inactivation process of platelet concentrates.
Topics: Adenine; Bacterial Infections; Blood Banking; Blood Preservation; DNA Primers; DNA, Mitochondrial; Electron Transport Complex IV; Furocoumarins; Humans; Photochemistry; Platelet Transfusion; Polymerase Chain Reaction; Quality Control; RNA, Ribosomal, 16S; Sensitivity and Specificity; Thymine; Ultraviolet Rays | 2005 |